Latest / Applied Clinical Trials
ACT Brief: Community Research Access, Trustworthy AI Assistants, and Individualized Gene Editing Guidance
In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.